Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Development of Medicated Topical Patches in Transdermal Drug Delivery System


Affiliations
1 SVU College of Pharmaceutical Scieincs, SV Univeristy, Tirupati, India
     

   Subscribe/Renew Journal


Transdermal drug delivery system is topically administered medicaments in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate. These devices allow for pharmaceuticals to be delivered across the skin barrier. Skin is a protective layer of the body, which acts as a barrier against physical, chemical and microbiological invasions. It also regulate the body temperature and blood pressure. The human skin is a readily accessible surface for drug delivery. In addition, Transdermal systems are non-invasive and can be self administered. Transdermal patch is the formulation which is expected to increase the solubility and bioavailability by penetrating poorly water soluble compounds through skin, and it is also possible for this formulation to decrease over-dosing and to avoid hepatic first pass metabolism. Transdermal delivery also has advantages over hypodermic injections, which are painful, generate dangerous medical waste and pose the risk of disease transmission by needle re-use. It has a variety of advantages compared with the oral route. This article mainly describes about composition of patch, types of patches and also explains detailed about evaluation of patches.

Keywords

Transdermal Patch, Hypodermic Injection, Polymers.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Sanju Nanda., KamalSaroha., BhavnaYadav., Benika Sharma., Int. J. Pharma and Chem. Sci, 1,(3), 2012, 953-969.

  • Vilegave k., Dantul B., Chandankar P., Kharjul A., Kharjul. M., Int. J. Pharma. Res. Sch, 2,(1), 2013, 71-82.

  • Sonia Dhiman., Thakur Gurjeet Singh., Ashish Kumar Rehni., Int. J. Pharm and Pharma.Sci, 3,(5), 2011, 26-34.

  • Archana K Gaikwad., Comp. J. Pharma. Sci, 1,(1), 2013, 1-10.

  • Dinesh L Dhamecha., Amit A Rathi., Maria Saifee., Swaroop R Lahoti., Mohd. Hassan G Dehghan., Int. J. Pharm and Pharma.Sci, 1,(1), 2009, 24-46.

  • KinjalRathod., Chetna Shah., HiralShah., Int. J. Pharma. Res and bio.sci, 3,(2), 2014, 540-554.

  • Farha Amna Shaik., ImranShaik Mohammad., Int. J. Inno. Pharma.sci and Res, 2,(1), 2014, 515-526.

  • Sandhu Premjeet., Ajay Bilandi., KatariaSahil., MiddhaAkanksha., Int. J. Res. Pharm and Chemistry, 1,(4), 2011, 1139-1151.

  • Richa Sachan., MeenakshiBajpai., Int. J. Res and Devlop in Pharm and Life.Sci, 3,(1), 2013, 748-765.

  • Saurabh Pandey., AshutoshBadola., Ganesh Kumar Bhatt., PreetiKothiyal., Int. J. Pharma and Chem. Sci, 2,(3), 2013, 1171-1180.

  • Jain Amit.K., SethiMittul., Int. J. Pharma. Studies and Res, 2,(1), 2011, 122-132.

  • Shaila Lewis., S Pandey., N Udupa., Ind. J. Pharma.Sci,68,(2), 2006, 179-184.

  • Karen Hitesh. D., Anand Indermeet.S., Patel Chhaganbhai. N., ChavdaHitesh. V., Patel Jitendra. K., J. Glo. Pharma. Tech, 2,(2), 2010, 75-78.

  • Shalini Asthana., Anil K. Jaiswal., Pramod K. Gupta., Vivek K. Pawar., Anuradha Dude., Manish K. Chourasia., Antimicro. Agents. Chemothera, 57, (4), 2013, 1714-1722.

  • Arvind.G., Sumit Shah., Shanmukha Mule., Prashanth.P., NoveenKonda., Int. J. pharm, 3,(3), 2013, 540-547.

  • Nadia.A. Hussein Al-Assady., EmanSaad., Inaam.M.N. Alrubayae., J. Basrah. Res(Sci), 39,(3), 2013, 114-131.

  • S.Sangeetha., Dhandapani Nagasamy Venkatesh., Rajendran Adhiyaman., Kumaraswamy Santhi., Bhojraj Suresh., Trop. J. Pharma. Res, 6,(1), 2007, 653-659.

  • http:// www.drugbank.ca/

  • Jodi. M.Lestner., Susan. J.Howard., Joanne Goodwin., Lea Gregson., Jayesh.M., Thomas.J.Walsh., Gerard. M. Jensen., William. W.Hope., Antimicro. Agent and Chemotherapy, 54,(8), 2010, 3432-3441.

  • Rowe RC., Sheskey PJ., Owen SC., Hand book of Pharmaceutical excipients 5th edition 2006, 545-550, 334-335.


Abstract Views: 228

PDF Views: 0




  • Development of Medicated Topical Patches in Transdermal Drug Delivery System

Abstract Views: 228  |  PDF Views: 0

Authors

Katta Manogna
SVU College of Pharmaceutical Scieincs, SV Univeristy, Tirupati, India
T. N. Shilpa
SVU College of Pharmaceutical Scieincs, SV Univeristy, Tirupati, India

Abstract


Transdermal drug delivery system is topically administered medicaments in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate. These devices allow for pharmaceuticals to be delivered across the skin barrier. Skin is a protective layer of the body, which acts as a barrier against physical, chemical and microbiological invasions. It also regulate the body temperature and blood pressure. The human skin is a readily accessible surface for drug delivery. In addition, Transdermal systems are non-invasive and can be self administered. Transdermal patch is the formulation which is expected to increase the solubility and bioavailability by penetrating poorly water soluble compounds through skin, and it is also possible for this formulation to decrease over-dosing and to avoid hepatic first pass metabolism. Transdermal delivery also has advantages over hypodermic injections, which are painful, generate dangerous medical waste and pose the risk of disease transmission by needle re-use. It has a variety of advantages compared with the oral route. This article mainly describes about composition of patch, types of patches and also explains detailed about evaluation of patches.

Keywords


Transdermal Patch, Hypodermic Injection, Polymers.

References